Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response
Ziqiang Chen,Xiaobing Wang,Zelin Jin,Bosen Li,Dongxian Jiang,Yanqiu Wang,Mengping Jiang,Dandan Zhang,Pei Yuan,Yahui Zhao,Feiyue Feng,Yicheng Lin,Liping Jiang,Chenxi Wang,Weida Meng,Wenjing Ye,Jie Wang,Wenqing Qiu,Houbao Liu,Dan Huang,Yingyong Hou,Xuefei Wang,Yuchen Jiao,Jianming Ying,Zhihua Liu,Yun Liu
DOI: https://doi.org/10.1038/s41698-024-00579-w
2024-03-22
npj Precision Oncology
Abstract:Abstract Tertiary lymphoid structures (TLSs) have been associated with favorable immunotherapy responses and prognosis in various cancers. Despite their significance, their quantification using multiplex immunohistochemistry (mIHC) staining of T and B lymphocytes remains labor-intensive, limiting its clinical utility. To address this challenge, we curated a dataset from matched mIHC and H&E whole-slide images (WSIs) and developed a deep learning model for automated segmentation of TLSs. The model achieved Dice coefficients of 0.91 on the internal test set and 0.866 on the external validation set, along with intersection over union (IoU) scores of 0.819 and 0.787, respectively. The TLS ratio, defined as the segmented TLS area over the total tissue area, correlated with B lymphocyte levels and the expression of CXCL13 , a chemokine associated with TLS formation, in 6140 patients spanning 16 tumor types from The Cancer Genome Atlas (TCGA). The prognostic models for overall survival indicated that the inclusion of the TLS ratio with TNM staging significantly enhanced the models’ discriminative ability, outperforming the traditional models that solely incorporated TNM staging, in 10 out of 15 TCGA tumor types. Furthermore, when applied to biopsied treatment-naïve tumor samples, higher TLS ratios predicted a positive immunotherapy response across multiple cohorts, including specific therapies for esophageal squamous cell carcinoma, non-small cell lung cancer, and stomach adenocarcinoma. In conclusion, our deep learning-based approach offers an automated and reproducible method for TLS segmentation and quantification, highlighting its potential in predicting immunotherapy response and informing cancer prognosis.
oncology